Amyloid heart disease

Yaser Nemshah, Alex Clavijo, Gyanendra Kumar Sharma

Research output: Contribution to journalArticle

Abstract

Cardiac amyloidosis is a group of disorders that develop secondary to the deposition of misfolded proteins in the heart. It can occur in isolation or as part of a systemic disease and can be inherited or acquired. Amyloid light chain (AL) and amyloid transthyretin (ATTR) are the two main forms of amyloid proteins that can infiltrate the heart. With the increased use of advanced imaging techniques and protocols, the recognition and diagnosis of cardiac amyloidosis, especially ATTR, has become easier. New therapies intended to improve survival and quality of life in patients with cardiac amyloidosis are emerging. This article provides an up-to-date review of cardiac amyloidosis.

Original languageEnglish (US)
Pages (from-to)113-118
Number of pages6
JournalUS Cardiology Review
Volume12
Issue number2
DOIs
StatePublished - Dec 1 2018

Fingerprint

Amyloidosis
Amyloid
Heart Diseases
Prealbumin
Amyloidogenic Proteins
Quality of Life
Light
Survival
Proteins
Therapeutics

Keywords

  • Cardiac amyloidosis
  • Cardiovascular MRI
  • Echocardiography
  • Immunoglobulin light chain amyloidosis
  • Scintigraphy
  • Transthyretin amyloidosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Amyloid heart disease. / Nemshah, Yaser; Clavijo, Alex; Sharma, Gyanendra Kumar.

In: US Cardiology Review, Vol. 12, No. 2, 01.12.2018, p. 113-118.

Research output: Contribution to journalArticle

Nemshah, Y, Clavijo, A & Sharma, GK 2018, 'Amyloid heart disease', US Cardiology Review, vol. 12, no. 2, pp. 113-118. https://doi.org/10.15420/usc.2018.5.1
Nemshah, Yaser ; Clavijo, Alex ; Sharma, Gyanendra Kumar. / Amyloid heart disease. In: US Cardiology Review. 2018 ; Vol. 12, No. 2. pp. 113-118.
@article{343c726e05b747fca64f219d26b4b733,
title = "Amyloid heart disease",
abstract = "Cardiac amyloidosis is a group of disorders that develop secondary to the deposition of misfolded proteins in the heart. It can occur in isolation or as part of a systemic disease and can be inherited or acquired. Amyloid light chain (AL) and amyloid transthyretin (ATTR) are the two main forms of amyloid proteins that can infiltrate the heart. With the increased use of advanced imaging techniques and protocols, the recognition and diagnosis of cardiac amyloidosis, especially ATTR, has become easier. New therapies intended to improve survival and quality of life in patients with cardiac amyloidosis are emerging. This article provides an up-to-date review of cardiac amyloidosis.",
keywords = "Cardiac amyloidosis, Cardiovascular MRI, Echocardiography, Immunoglobulin light chain amyloidosis, Scintigraphy, Transthyretin amyloidosis",
author = "Yaser Nemshah and Alex Clavijo and Sharma, {Gyanendra Kumar}",
year = "2018",
month = "12",
day = "1",
doi = "10.15420/usc.2018.5.1",
language = "English (US)",
volume = "12",
pages = "113--118",
journal = "US Cardiology",
issn = "1758-3896",
publisher = "Radcliffe Publishing Ltd.",
number = "2",

}

TY - JOUR

T1 - Amyloid heart disease

AU - Nemshah, Yaser

AU - Clavijo, Alex

AU - Sharma, Gyanendra Kumar

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Cardiac amyloidosis is a group of disorders that develop secondary to the deposition of misfolded proteins in the heart. It can occur in isolation or as part of a systemic disease and can be inherited or acquired. Amyloid light chain (AL) and amyloid transthyretin (ATTR) are the two main forms of amyloid proteins that can infiltrate the heart. With the increased use of advanced imaging techniques and protocols, the recognition and diagnosis of cardiac amyloidosis, especially ATTR, has become easier. New therapies intended to improve survival and quality of life in patients with cardiac amyloidosis are emerging. This article provides an up-to-date review of cardiac amyloidosis.

AB - Cardiac amyloidosis is a group of disorders that develop secondary to the deposition of misfolded proteins in the heart. It can occur in isolation or as part of a systemic disease and can be inherited or acquired. Amyloid light chain (AL) and amyloid transthyretin (ATTR) are the two main forms of amyloid proteins that can infiltrate the heart. With the increased use of advanced imaging techniques and protocols, the recognition and diagnosis of cardiac amyloidosis, especially ATTR, has become easier. New therapies intended to improve survival and quality of life in patients with cardiac amyloidosis are emerging. This article provides an up-to-date review of cardiac amyloidosis.

KW - Cardiac amyloidosis

KW - Cardiovascular MRI

KW - Echocardiography

KW - Immunoglobulin light chain amyloidosis

KW - Scintigraphy

KW - Transthyretin amyloidosis

UR - http://www.scopus.com/inward/record.url?scp=85058819092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058819092&partnerID=8YFLogxK

U2 - 10.15420/usc.2018.5.1

DO - 10.15420/usc.2018.5.1

M3 - Article

AN - SCOPUS:85058819092

VL - 12

SP - 113

EP - 118

JO - US Cardiology

JF - US Cardiology

SN - 1758-3896

IS - 2

ER -